Extracorporeal Shock Wave Therapy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Mobile Shock Wave Therapy Devices, Fixed Shock Wave Therapy Devices), By Technology (Electromagnetic Technique, Electrohydraulic Technique, Piezoelectric Technique, Radial Technique), By Application (Kidney Stones, Pancreatic Stones, Uretic Stones, Salivary Stones, Musculoskeletal Disorders), By End-User (Hospitals, Physiotherapy Centres, Ambulatory Surgical Centres, Clinics, Radiology Labs, Others) and Region Forecast 2020-2031

Extracorporeal shock wave therapy market size was valued at US$ 108.7 million in 2024 and is expected to reach US$ 166.7 million by 2031, growing at a significant CAGR of 6.3% from 2025-2031. Market (ESWT) is developed for the treatment of gall and kidney stones. Extracorporeal shock wave therapy has been used to treat rise in number of musculoskeletal conditions, like rotator cuff tendinitis, tennis elbow, patellar tendinopathy, plantar fasciitis, bony non-unions and Achilles tendinopathy. Shock wave therapy devices are non-invasive treatment for the musculoskeletal pain and dbbbcan be used frequently in urology, physiotherapy, sports medicine, veterinary medicine and orthopaedic.

It is also called as Extracorporeal Shock Wave Therapy (ESWT). Abrupt, high amplitude mechanical energy pulses are generated with help of the electromagnetic coil to manage and reduce the pain in ESWT process. ESWT is an alternative for surgery and also helps in speedy recovery of patients who are suffering from various tendon, muscle and joint disorders.

Extracorporeal Shock Wave Therapy (ESWT) market is expected to register a significant CAGR over a forecast period. As the sports-related injuries are common issues, ESWT market has gained more popularity by the sport clinicians and athletes. ESWT devices have received FDA-approval for lateral epicondylitis and plantar fasciitis. According to Health and Safety Executive, the UK, 41% of ill health was encountered among the UK employees due to work-related musculoskeletal disorders (WRMSD), accounting for around 1,311,000 cases in 2014. Furthermore, as per to the Centre for Disease Control about 22.7% of adults are diagnosed with various kind of arthritis, which is accounting around 54.4 million cases from 2013-2015. The high prevalence rate of musculoskeletal disorders creates a highly conducive environment for growth of shock wave therapy devices market.

Key Developments 

• Dornier Epos Ultra by Dornier Medical Systems, Inc., Kennesaw, GA, USA was approved for treatment of chronic plantar fasciitis for patients with symptoms of plantar fasciitis for 6Â months or more and a history of unsuccessful conservative therapy In 2002